Bridging the Gap
Since 2010, Terrell Herring has worked as president of commercial operations at Mission Pharmacal, a pharmaceutical company based in San Antonio, Texas. Since 2011, he has simultaneously served as president of the Doylestown, Pennsylvania-based Mission Pharmacal affiliate Alamo Pharma Services. Outside of his professional life, Terrell Herring supports organizations including Bridging the Gap Africa, where he serves on the board of directors.
Bridging the Gap Africa (BtGA) is a nonprofit organization that helps rural communities in Kenya build footbridges to cross otherwise impassable rivers. The organization’s founders recognized that the impossibility of crossing dangerous floodwaters often prevented rural Kenyans from getting life-saving support, access to educational facilities, and transport to the market to sell their crops.
Through BtGA, the footbridge recipients are involved in each step of the bridge-building process. The community begins by seeking BtGA’s assistance. BtGA then works with the community to incorporate volunteers into the project, gathering materials and raising a portion of the costs. BtGA provides financial assistance as well as technical expertise, overseeing the community’s construction of the footbridge. Once complete, the community claims ownership of the bridge through a formal ceremony that includes singing, speeches, food, and gifts.
To find out how you can contribute to Bridging the Gap Africa, visit www.bridgingthegapafrica.org.
March for Babies
Terrell Herring, an executive for both Mission Pharmacal based in San Antonio, Texas and its subsidiary Alamo Pharma Services, extends his professional interest in healthcare to charitable activities outside of work. As commercial operations president at Mission Pharmacal and as a private citizen, Terrell Herring supports the March of Dimes Foundation® and its signature fundraiser, March for Babies. As a corporate sponsor, Mission Pharmacal commits time and money to support the March of Dimes Foundation’s mission to give babies a healthy start.
This year, Mission Pharmacal kicked off its March for Babies fundraising campaign in February, culminating with a march in San Antonio in mid-May. According to its website, the March of Dimes Foundation carries out its mission through research, education, and community service programs nationwide. Mission Pharmacal partners with the Foundation to raise awareness among women about the importance of folic acid intake before and during pregnancy to prevent birth defects of the brain and spine. As a March of Dimes Foundation partner the past eight years, Mission Pharmacal has raised more than $2.1 million for its initiatives.
Currently serving as the president of Alamo Pharma Services in Doylestown, Pennsylvania, Terrell “Terry” Herring oversees the marketing and growth of the company. Terrell “Terry” Herring also serves as the current president of commercial operations for San Antonio-based Mission Pharmacal Company (Mission), where he manages the daily operations and determines which healthcare products the company needs to promote.
Started in 1946, Mission was established to help improve family lives with high-quality, innovative products that include over-the-counter drugs along with prescription medications. Mission is well-known for its healthcare products dealing with dermatology and women’s health.
Mission produces a number of healthcare products across several therapeutic areas including urology, pediatrics, and women’s health. Mission also has several wholly-owned subsidiaries including Alamo Pharma Services, BioComp Pharma, BexR Logistix, EPIC Fulfillment, ProSolus, and Espada Dermatology. Espada offers both prescription and non-prescription products including Glyderm, a skincare product that helps skin texture look healthier and younger. Glyderm comes in a variety of applications, ranging from face cleanser and mist to hand, body, and face lotion.
Bridging the Gap
The president of commercial operations at Mission Pharmacal, Terrell (“Terry”) Herring also lends his time and expertise to charitable undertakings. Terrell Herring serves on the Board of Directors of the nonprofit organization, Bridging the Gap Africa (BtGA).
BtGA assists local communities in building footbridges across dangerous rivers in rural areas of Kenya. These footbridges have a powerful positive impact in the local communities. Aside from allowing for safe river passage, preventing drowning, and providing an unimpeded route to schools and health care centers, they also improve economic activity.
Just as important, BtGA helps communities help themselves. Local communities must initiate their own bridge undertaking by requesting assistance from BtGA. While the nonprofit provides financial and technical support in building a safe footbridge, the local community must raise a portion of the footbridge cost and enlist volunteer labor for rock and sand gathering to be used for the bridge footings. After project completion, ownership of the bridge is turned over to the local community.
The president of Alamo Pharma Services and the president of commercial operations for Mission Pharmacal, Terrell (Terry) Herring has decades of experience in the pharmaceutical industry. Alongside his work with these companies, Terrell Herring serves on the advisory board for BioAgilytix.
Through an extensive team of scientists and quality assurance professionals, BioAgilytix seeks innovative solutions for the cure and treatment of disease. In particular, the company targets the eradication of cancer through its research in the field of immuno-oncology.
Focused on assisting the immune system in the elimination of cancerous cells, immuno-oncology began in the early 1900s. Since then, studies have continued to show how effectively the immune system can eliminate tumors.
Although still a relatively new area of study, immuno-oncology offers hope of targeted cancer treatment replacing current practices such as chemotherapy. Promising examples for immunotherapy include sending monoclonal antibodies to attack cancer-specific antigens and employing certain molecules that inhibit the growth of specific lymphocytes surface markers.
March of Dimes
In addition to his work as is president of commercial operations at Mission Pharmacal Company, Terrell Herring takes an active role in a number of the company’s subsidiaries, including Alamo Pharma Services, BioComp Pharmaceuticals, and ProSolus Pharma. In addition, Terrell Herring is involved in the Mission Family of Companies’ support of the March of Dimes, an organization that works to reduce premature birth rates.
Recently, the March of Dimes teamed with the Centers for Disease Control and Prevention (CDC) to improve health for children exposed to drugs before birth. The partnership will look at Vermont, Illinois, and New Mexico, the three states with the highest incidence of neonatal abstinence syndrome (NAS), to evaluate the services that these children most need in their first months of life. When infants start their lives in withdrawal, they face a number of challenges. Understanding their needs can help ensure recovery.
In addition, these three states will gain valuable insight on why so many babies are being born exposed to drugs in the neonatal environment. This awareness could help create new programs and resources for women who are pregnant. Both organizations hope that the lessons learned in these three states will help other mothers and children across the nation.v
Bigs in Blue Initiative
The president of Alamo Pharma Services and the president of commercial operations at Mission Pharmacal Company, Terrell “Terry” Herring leverages his extensive business leadership experience in his work. Further, Terrell Herring is a former trustee for the Big Brothers Big Sisters of America (BBBSA), which awarded him the honor of Big Brother of the Year in 2007.
The BBBSA is a nonprofit organization that matches underserved children, which it names “Littles,” with adult mentors, named “Bigs,” who can provide children with guidance and advice relating to their lives and circumstances. Among the numerous initiatives that the BBBSA manages is the Bigs in Blue campaign, which offers Littles the opportunity to connect with law enforcement officers in their communities and learn more about what police do and how they can help. Through the campaign, the BBBSA hopes to foster stronger relationships between children, families, and the law enforcement professionals who serve them.
The BBBSA’s current goal is to expand the Bigs in Blue campaign so it becomes operational in at least one-third of its 300 affiliate locations throughout the United States. To achieve this aim BBBSA hopes to raise $5 million, which it will distribute to affiliates in the form of grants for program development.